CHAPEL HILL, N.C.--(BUSINESS WIRE)--Aug. 27, 2003--POZEN Inc.
(NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the
company's chairman, president and chief executive officer, will be
speaking to investors at three upcoming investor conferences:
Thomas Weisel Partners Healthcare Tailwinds Conference on
Wednesday, September 3, at 3:50 p.m. Eastern Time.
NewsMakers in the Biotech Industry Conference on Thursday,
September 4, at 9:00 a.m. Eastern Time.
Bear Stearns 16th Annual Healthcare Conference on Monday,
September 8, at 2:30 p.m. Eastern Time.
Dr. Plachetka will provide an overview of POZEN's business. The
presentations will be webcast live and archived on POZEN's home page
POZEN is a pharmaceutical company developing therapeutic
advancements in a cost effective manner. Product development efforts
are focused on diseases with unmet medical needs where POZEN can
improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has developed the largest and most advanced product
pipeline in the field of migraine. POZEN has development and
commercial alliances with GlaxoSmithKline and Nycomed. The company's
common stock is traded on The Nasdaq Stock Market under the symbol
"POZN". For detailed company information, including copies of this and
other press releases, see POZEN's website: www.pozen.com.
Chief Financial Officer
Director, Investor Relations